Factory wholesale Lapatinib Intermediate - 5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin Intermediate Factory – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

We will devote ourselves to giving our esteemed buyers using the most enthusiastically thoughtful services for CAS 100331-89-3, Formoterol Fumarate CAS 43229-80-7, Molecular Formula C11H8ClF3O3, Our company is working by the operation principle of "integrity-based, cooperation created, people oriented, win-win cooperation". We hope we can have a friendly relationship with businessman from all over the world.

Factory wholesale Lapatinib Intermediate - 5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin Intermediate Factory – Ruifu Detail:

Manufacturer Supply, High Purity, Commercial Production
Dapagliflozin (CAS: 461432-26-8) Related Intermediates:
5-Bromo-2-Chlorobenzoic Acid CAS 21739-92-4
5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS 32384-65-9

Chemical Name	5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane
Synonyms	4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzene; 4-(5-Brom-2-Chlorbenzyl)phenyl-Ethylether; Dapagliflozin Bromo Impurity
CAS Number	461432-23-5
CAT Number	RF-PI447
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C15H14BrClO
Molecular Weight	325.63
Melting Point	41.0 to 43.0℃
Brand	Ruifu Chemical

Item	Specifications
Appearance	White to Pael Yellow Crystalline Powder
Purity / Analysis Method	≥99.0% (HPLC)
Water (K.F)	≤0.50%
Total Impurities	≤1.0%
Test Standard	Enterprise Standard
Usage	Intermediate of Dapagliflozin (CAS: 461432-26-8), type II diabetes

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzene (CAS: 461432-23-5) is used as a intermediate in the synthesis of Dapagliflozin (CAS: 461432-26-8). Dapagliflozin is a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. Dapagliflozin is a new antidiabetic drug jointly developed by Bristol-Myers Squibb and AstraZeneca, being approved by the European Medicines Agency (EMA) on November 12, 2012. On January 8, 2014, the US Food and Drug Administration (FDA) have approved it for being used in the treatment of type II diabetes.

Product detail pictures:

Related Product Guide:

Fast and good quotations, informed advisers to help you choose the correct product that suits all your needs, a short production time, responsible quality control and different services for paying and shipping affairs for Factory wholesale Lapatinib Intermediate - 5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin Intermediate Factory – Ruifu , The product will supply to all over the world, such as: Germany, Florida, St. Petersburg, Our company follows laws and international practice. We promise to be responsible for friends, customers and all partners. We would like to establish a long-term relationship and friendship with every customer from all over the world on the basis of mutual benefits. We warmly welcome all old and new customers to visit our company to negotiate business.